Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
265,214,861
Total 13F shares
14,193,703
Share change
-940,576
Total reported value
$17,600,522
Put/Call ratio
10%
Price per share
$1.24
Number of holders
27
Value change
-$1,644,775
Number of buys
7
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
HHLR ADVISORS, LTD.
13F
Company
2.6%
6,909,220
$11,538,397 30 Jun 2024
13F
Caligan Partners LP
13F
Company
1.3%
3,374,791
$5,635,901 30 Jun 2024
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.52%
1,379,352
$2,303,518 30 Jun 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.22%
576,600
$962,922 30 Jun 2024
13F
Temasek Holdings (Private) Ltd
13F
Company
0.21%
566,650
$946,306 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.18%
478,442
$798,998 30 Jun 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.1%
272,193
$455,000 30 Jun 2024
13F
Exome Asset Management LLC
13F
Company
0.1%
271,400
$453,238 30 Jun 2024
13F
BANK OF MONTREAL /CAN/
13F
Company
0.09%
244,875
$453,019 30 Jun 2024
13F
EDBI Pte Ltd
13F
Company
0.08%
222,136
$370,967 30 Jun 2024
13F
Aberdeen Group plc
13F
Company
0.06%
162,580
$271,509 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.04%
102,961
$171,945 30 Jun 2024
13F
Alberta Investment Management Corp
13F
Company
0.03%
74,723
$124,787 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
63,800
$106,546 30 Jun 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.02%
58,358
$97,458 30 Jun 2024
13F
Invesco Ltd.
13F
Company
0.02%
57,933
$96,748 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.02%
40,308
$67,314 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.01%
38,708
$64,642 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
34,347
$57,359 30 Jun 2024
13F
Mariner, LLC
13F
Company
0.01%
31,535
$52,663 30 Jun 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.01%
31,066
$51,880 30 Jun 2024
13F
BARCLAYS PLC
13F
Company
0.01%
30,370
$50,718 30 Jun 2024
13F
Donald L. Hagan, LLC
13F
Company
0.01%
30,000
$50,100 30 Jun 2024
13F
XTX Topco Ltd
13F
Company
0.01%
17,876
$29,853 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.01%
15,750
$26,303 30 Jun 2024
13F
MARSHALL WACE, LLP
13F
Company
0.01%
14,064
$23,488 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.01%
13,880
$23,180 30 Jun 2024
13F
UBS Group AG
13F
Company
0%
12,514
$20,898 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
0%
7,684
$12,833 30 Jun 2024
13F
Qube Research & Technologies Ltd
13F
Company
0%
2,565
$4,284 30 Jun 2024
13F
RHUMBLINE ADVISERS
13F
Company
0%
1,367
$2,282 30 Jun 2024
13F
Legal & General Group Plc
13F
Company
0%
1,191
$1,988 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
568
$949 30 Jun 2024
13F
Frazier Financial Advisors, LLC
13F
Company
0%
515
$861 30 Jun 2024
13F
Catalyst Funds Management Pty Ltd
13F
Company
0%
90
$150 30 Jun 2024
13F
GAMMA Investing LLC
13F
Company
0%
63
$105 30 Jun 2024
13F
CITIGROUP INC
13F
Company
0%
50
$84 30 Jun 2024
13F

Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2024

As of 30 Sep 2024, NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,193,703 shares. The largest 10 holders included HHLR ADVISORS, LTD., Caligan Partners LP, BOOTHBAY FUND MANAGEMENT, LLC, Temasek Holdings (Private) Ltd, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, EDBI Pte Ltd, abrdn plc, CITADEL ADVISORS LLC, and Alberta Investment Management Corp. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
37
Q3 2024 holders
27
Holder diff
-10
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.